I agree that this site is using cookies. You can find further informations here.
X
Silberstein, Peter
117  results:
OpenAccess-fulltext X
Search for persons X
?
1

Treatment trends of muscle invasive bladder cancer: Evidenc..:

Chalfant, Victor ; Blute, Michael L ; Silberstein, Peter
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875153/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Role of daratumumab in relapsed or refractory multiple myel..:

Tauseef, Abubakar ; Zafar, Maryam ; Silberstein, Peter...
10.4103/jfmpc.jfmpc_1987_21.  , 2022
Link: https://hdl.handle.net/1..
 
?
3

Safety Profile of Mutant EGFR-TK Inhibitors in Advanced Non..:

Tauseef, Abubakar ; Zafar, Maryam ; Silberstein, Peter...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662311/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

Comparison of darbepoetin alfa dosed weekly (QW) vs. extend..:

Schwartzberg, Lee ; Burkes, Ronald ; Mirtsching, Barry...
http://www.biomedcentral.com/1471-2407/10/581.  , 2010
Link: http://www.biomedcentral..
 
?
5

Comparison of darbepoetin alfa dosed weekly (QW) vs. extend..:

Silberstein Peter ; Rearden Timothy ; Mirtsching Barry...
http://www.biomedcentral.com/1471-2407/10/581.  , 2010
Link: https://doi.org/10.1186/..
 
?
6

Presentation of a Rare Malignancy: Leiomyosarcoma of the Pr..:

Ermann, Daniel A ; Noble, Victoria V ; Fazeel, Hafiz M..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411357/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
7

Treatment Facility: An Important Prognostic Factor for Dedi..:

Gootee, Jonathan Michael ; Curtin, Christina E ; Aurit, Sarah J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719806/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
8

Impact of siltuximab on patient-related outcomes in multice..:

Sitenga, Jenna ; Aird, Gregory ; Ahmed, Aabra.
info:eu-repo/semantics/altIdentifier/doi/10.2147/PROM.S140011.  , 2018
Link: https://www.dovepress.co..
 
?
9

Impact of siltuximab on patient-related outcomes in multice..:

Sitenga, Jenna ; Aird, Gregory ; Ahmed, Aabra.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769562/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
10

Factors Affecting Adjuvant Therapy in Stage III Pancreatic ..:

Krishnan, Mridula ; Ahmed, Aabra ; Walters, Ryan W.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582659/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
11

Reduced-intensity conditioning allogeneic hematopoietic-cel..:

Goyal, Gaurav ; Gundabolu, Krishna ; Vallabhajosyula, Saraschandra..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872178/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
12

Chemotherapy use in stage III colon cancer: a National Canc..:

Upadhyay, Smrity ; Dahal, Sumit ; Bhatt, Vijaya Raj..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543852/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
13

Clinicopathologic characteristics and management trends of ..:

Bhatt, Vijaya Raj ; Shrestha, Rajesh ; Krishnamurthy, Jairam...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
14

Colorectal Carcinoma and Emerging Targeted Therapies:

Khanal, Nabin ; Upadhyay, Smrity ; Silberstein, Peter T
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375427/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
15

Demographic and other characteristics of nodal non-Hodgkin'..:

Bhatt, Vijaya Raj ; Dhakal, Prajwal ; Dahal, Sumit...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556968/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
1-15